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2012 Annual Report for the Emerging Infections Program for Clostridium difficile Infection
In 2012, a total of 16,449 cases of C. difficile infection (CDI) were reported to the Emerging Infections Program
(EIP) in 35 counties with continuous reporting in 10 US states (California, Colorado, Connecticut, Georgia,
Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee).
The overall distribution of EIP CDI cases and crude incidence by selected demographic factors and epidemiologic
classification are presented in Table 1. Data in this report are not intended to be directly compared to annual
reports from other years, and should not be used to determine annual changes in EIP CDI incidence rates
because single year calculations do not account for changes in testing practices by reporting facilities.
Table 1. Reported Number of CDI Cases and Crude Incidence by Sex, Age Group, Race, and Epidemiological
Classification Among the 10 EIP Sitesa
Demographic
Characteristic
Population ≥1
Year of Age
Community Associated
CDIb
Healthcare Associated
CDIb
All CDI
No. Incidencec No. Incidencec No. Incidencec 
Sex
Male 5533992 2243 40.53 4497 81.26 6740 121.79
Female 5749334 3724 64.77 5985 104.10 9709 168.87
Age group
1-17 years 2506177 414 16.52 187 7.46 601 23.98
18-44 years 4467587 1444 32.32 975 21.82 2419 54.15
45-64 years 2974510 1991 66.94 2566 86.27 4557 153.20
≥65 years 1335052 2118 158.65 6754 505.90 8872 664.54
Race
White 7854051 4924 62.69 8135 103.58 13059 166.27
Non-white 3429275 1043 30.41 2347 68.44 3390 98.85
Totald 11283326 5967 52.88 10482 92.90 16449 145.78
a The epidemiologic classification was statistically imputed for 0.7% of the observed CDI cases, and race was
statistically imputed for 21.1% of the observed CDI cases. The weighted frequency of cases in Colorado and
Georgia were based on 33% random sampling.
b A CDI case was classified as community-associated if the C. difficile-positive stool specimen was collected on an
outpatient basis or within 3 days after hospital admission in a person with no documented overnight stay in a 
healthcare facility in the preceding 12 weeks. All CDI cases that do not meet the aforementioned criteria were
classified as healthcare-associated.
c Cases per 100,000 persons.
d Data presented in the table excludes cases from Olmsted County, Minnesota, where CDI surveillance began
mid-year. The total number of reported CDI cases in 2012 would be 16,564 if CDI cases from Olmsted County,
Minnesota were included.
Laboratory Characterization of C. difficile Isolates
In 2012, a total of 1,443 C. difficile isolates were available for further analysis. The total number of isolates
received from each site ranged from 55 to 232, with a median of 154.5. The majority of the isolates (96%) were
collected in metropolitan areas.
Among all available isolates, 156 distinct ribotypes were detected. Ribotypes 027, 106, 002, 020 and 014 were
the most common observed in both community- and healthcare-associated C. difficile isolates (Tables 2 and 3).
              
          
      
   
   
   
   
   
   
   
   
   
   
   
   
      
   
   
   
   
   
   
   
   
   
   
   
      
      
      
      
Thirty-one percent of the isolates harbored a deletion in tcdC. Thirty percent of the isolates were binary toxin-
positive, and among these, ribotypes 027, 078 and 019 predominated.
Table 2. Frequency of Ribotypes Among Community- Table 3. Frequency of Ribotypes Among Healthcare-
Associated C. difficile Isolates, 2012 (n=801) Associated C. dfficile Isolates, 2012 (n=642)
Ribotype No of isolates % isolates
027 137 17%
106 74 9%
002 70 9%
020 52 6%
014 42 5%
056 36 4%
001_072 26 3%
078 24 3%
015 20 2%
019 17 2%
Others 303 38%
Ribotype No of isolates % isolates
027 136 21%
106 55 9%
002 36 6%
020 34 5%
014 29 5%
054 21 3%
078 19 3%
017 19 3%
053 18 3%
A12 15 2%
046 15 2%
Others 245 38%
